Allergan Finance LLC, founded in 2013 and headquartered in Irvine, California, operates as a financial service provider focusing on the pharmaceutical and medical aesthetics sectors. The company specializes in offering various financial solutions, including debt financing and a range of investment products related to its parent company, AbbVie Inc., a global pharmaceutical leader.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| AGN 4.63% 2042-10-01 USDAllergan Finance LLC | United States | 2042-10-01 | 4.625 | 6.70 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Allergan Finance has actively issued bonds since its inception, with a notable offering in 2019 amounting to $3 billion, primarily to fund corporate acquisitions and strengthen its balance sheet. Current yields on its bonds are competitive within the healthcare sector, often reflecting the company’s strong credit profile and market demand. One significant feature of these bonds includes their callable structure, which provides Allergan the flexibility to manage its debt portfolio effectively. Recent news highlights Allergan's strategic focus on expanding its product pipeline, which may influence future bond issuance strategies.